David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared a post on LinekdIn:
“Excellent overview by Raffaele Califano of the strategic breakthroughs for NSCLC EGFRm patients and the FLAURA2 first-line setting.”
Other articles about NSCLC on OncoDaily.
